DenosumabRebound effect in form of hypophosphataemic osteomalacia: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1830卷 / 1期

关键词：

D O I：

10.1007/s40278-020-86082-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：132 / 132

相关论文

共 50 条

[1] FerrioxypolymaltoseFirst report of hypophosphataemic osteomalacia: case report
[J]. Reactions Weekly, 2009, 1253 (1) : 17 - 18
[2] DenosumabRebound effect in the form of hypercalcaemia: case report
[J]. Reactions Weekly, 2023, 1961 (1) : 154 - 154
[3] AdefovirFanconi syndrome and hypophosphataemic osteomalacia: case report
[J]. Reactions Weekly, 2011, 1352 (1) : 6 - 6
[4] Denosumabrebound effect in the form of vertebral fracture: case report
[J]. Reactions Weekly, 2022, 1916 (1) : 174 - 174
[5] Iron sucroseHaemochromatosis and hypophosphataemic osteomalacia: case report
[J]. Reactions Weekly, 2015, 1541 (1) : 169 - 169
[6] DenosumabRebound effect in the form of tibia and femur fractures: case report
[J]. Reactions Weekly, 2021, 1851 (1) : 131 - 131
[7] TenofovirTubular dysfunction leading to hypophosphataemic osteomalacia: case report
[J]. Reactions Weekly, 2011, 1355 (1) : 34 - 34
[8] Adefovir dipivoxilFanconi syndrome and hypophosphataemic osteomalacia: case report
[J]. Reactions Weekly, 2016, 1612 (1) : 12 - 12
[9] Adefovir dipivoxilFanconi's syndrome and hypophosphataemic osteomalacia: case report
[J]. Reactions Weekly, 2015, 1554 (1) : 18 - 18
[10] Adefovir dipivoxilFanconi’s syndrome and hypophosphataemic osteomalacia: case report
[J]. Reactions Weekly, 2010, 1295-1296 (1) : 6 - 6

← 1 2 3 4 5 →